Print   

Wednesday 18 November, 2009

Corin Group PLC

Interim Management Statement

RNS Number : 6595C
Corin Group PLC
18 November 2009
 



18 November 2009


Corin Group PLC 


Interim Management Statement 


Corin Group PLC (LSE: CRG, "Corin" or "the Group"), a leading manufacturer and supplier of orthopaedic devices, is today publishing an Interim Management Statement for the period from 1 July to 17 November 2009.


In the period ended 31 October 2009, the Group traded broadly in line with the Board's expectations. Underlying constant currency sales growth has been in line with the 10% level achieved in the first half year. The Board expects the growth rate to be at a similar level for the remainder of the 2009 financial year.


Geographical sales trends in the first half have continued into the second half. Sales in Japan and Australia have continued to grow strongly. Sales in Continental Europe have been marginally ahead of the comparative period, representing a slight improvement on the first half. Sales in the UK domestic market have been relatively weak. Whilst margins have been affected adversely by the average US$:£ exchange rate in the second half of $1.63, compared to $1.49 in the first halfthis has to some extent been offset by the weakness of Sterling against the Australian dollar.


Sales to Stryker have been in line with expectations at levels more closely reflecting Stryker's implant rate.


Corin's new Trinity acetabular system (see note to editors) was approved by the UK regulator on 26 October 2009 and the first evaluation surgery using the cup was carried out on 12 November. While sales of the cup will not materially impact the 2009 results, the evaluation of this product is proceeding in line with the Board's timetable to date.


Corin expects to publish its preliminary results for the year ending 31 December 2009 early in March 2010.


Peter Huntley, Corin's Chief Executive, commented


"We are pleased with the progress of our new product development programme and the start of evaluation surgeries for the Trinity system is a significant milestone in this regard."


Enquiries:


Corin Group PLC

 

Peter Huntley, Chief Executive

Michael Roller, Finance Director

 01285 659 866

 

 

College Hill

 

Adrian Duffield/Rozi Morris

020 7457 2020


Note to editors:

The Trinity acetabular system is a multi-liner acetabular cup allowing ceramic-on-ceramic, metal-on-polyethylene or metal-on-metal bearing couples in total hip replacement surgery.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFFIFMWSUSELF

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.